NCT05429567View on ClinicalTrials.gov

Effectiveness of Patient-Controlled Intravenous Analgesia (PCIA) With Fentanyl

PHASE1CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

February 1, 2022

Study Completion Date

February 28, 2022

Conditions
Total Hip Replacement
Interventions
DRUG

Fentanyl

All patients underwent combined spinal and epidural anesthesia (CSEA) with 2 ml of 0.5 % hyperbaric bupivacaine and 25 ug fentanyl administered using a 27-gauge Whitacre spinal needle and an 18-gauge Tuohy needle in the epidural space. The epidural space was identified utilizing the loss of resistance approach

Trial Locations (1)

Unknown

October 6 University, Giza

All Listed Sponsors
collaborator

October 6 University

OTHER

lead

Egymedicalpedia

INDUSTRY

NCT05429567 - Effectiveness of Patient-Controlled Intravenous Analgesia (PCIA) With Fentanyl | Biotech Hunter | Biotech Hunter